Published in Mol Pharmacol on February 05, 2008
The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation. EMBO J (2010) 3.76
Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J (2009) 2.89
Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol (2012) 1.72
Clinical development of novel proteasome inhibitors for cancer treatment. Expert Opin Investig Drugs (2009) 1.22
Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth. J Ovarian Res (2010) 1.22
Dietary curcumin increases antioxidant defenses in lung, ameliorates radiation-induced pulmonary fibrosis, and improves survival in mice. Radiat Res (2010) 1.22
Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications. Int J Nanomedicine (2012) 1.07
New perspectives of curcumin in cancer prevention. Cancer Prev Res (Phila) (2013) 1.05
Distinct combinatorial effects of the plant polyphenols curcumin, carnosic acid, and silibinin on proliferation and apoptosis in acute myeloid leukemia cells. Nutr Cancer (2010) 1.03
Energy deprivation by silibinin in colorectal cancer cells: a double-edged sword targeting both apoptotic and autophagic machineries. Autophagy (2013) 0.97
Berberine radiosensitizes human esophageal cancer cells by downregulating homologous recombination repair protein RAD51. PLoS One (2011) 0.97
Involvement of ROS in Curcumin-induced Autophagic Cell Death. Korean J Physiol Pharmacol (2011) 0.97
Curcumin-the paradigm of a multi-target natural compound with applications in cancer prevention and treatment. Toxins (Basel) (2010) 0.93
Curcumin regulates low-linear energy transfer γ-radiation-induced NFκB-dependent telomerase activity in human neuroblastoma cells. Int J Radiat Oncol Biol Phys (2011) 0.87
Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients. Radiat Res (2013) 0.86
Mitochondrial-targeted curcuminoids: a strategy to enhance bioavailability and anticancer efficacy of curcumin. PLoS One (2014) 0.84
Thioredoxin reductase-1 mediates curcumin-induced radiosensitization of squamous carcinoma cells. Cancer Res (2010) 0.83
Clinical comparison of dose calculation using the enhanced collapsed cone algorithm vs. a new Monte Carlo algorithm. Strahlenther Onkol (2011) 0.82
Cyclooxygenase-1 and -2: molecular targets for cervical neoplasia. J Cancer Prev (2013) 0.82
ERK plays the baddie (again). Cancer Biol Ther (2013) 0.81
Agaricus blazei Extract Induces Apoptosis through ROS-Dependent JNK Activation Involving the Mitochondrial Pathway and Suppression of Constitutive NF-κB in THP-1 Cells. Evid Based Complement Alternat Med (2011) 0.79
Curcumin enhances paraquat-induced apoptosis of N27 mesencephalic cells via the generation of reactive oxygen species. Neurotoxicology (2009) 0.79
The chemopreventive and clinically used agent curcumin sensitizes HPV (-) but not HPV (+) HNSCC to ionizing radiation, in vitro and in a mouse orthotopic model. Cancer Biol Ther (2012) 0.79
Small molecule tolfenamic acid and dietary spice curcumin treatment enhances antiproliferative effect in pancreatic cancer cells via suppressing Sp1, disrupting NF-kB translocation to nucleus and cell cycle phase distribution. J Nutr Biochem (2016) 0.77
Vanadium compounds discriminate hepatoma and normal hepatic cells by differential regulation of reactive oxygen species. J Biol Inorg Chem (2010) 0.77
Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2. Oncotarget (2016) 0.76
Properties of lewis lung carcinoma cells surviving curcumin toxicity. J Cancer (2011) 0.76
Phenylpropanoids in radioregulation: double edged sword. Exp Mol Med (2011) 0.76
Characterization of a novel curcumin analog P1 as potent inhibitor of the NF-κB signaling pathway with distinct mechanisms. Acta Pharmacol Sin (2013) 0.75
Relationship and interactions of curcumin with radiation therapy. World J Clin Oncol (2016) 0.75
Exceedingly Higher co-loading of Curcumin and Paclitaxel onto Polymer-functionalized Reduced Graphene Oxide for Highly Potent Synergistic Anticancer Treatment. Sci Rep (2016) 0.75
Curcumin mitigates accelerated aging after irradiation in Drosophila by reducing oxidative stress. Biomed Res Int (2015) 0.75
MiR-593 mediates curcumin-induced radiosensitization of nasopharyngeal carcinoma cells via MDR1. Oncol Lett (2016) 0.75
Appraisal of biochemical classes of radioprotectors: evidence, current status and guidelines for future development. 3 Biotech (2017) 0.75
Antiproliferative activity of Haematoxylum brasiletto H. Karst. Pharmacogn Mag (2017) 0.75
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med (1999) 7.56
Nuclear factor-kappaB: the enemy within. Cancer Cell (2004) 6.86
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest (2001) 5.87
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res (2001) 5.78
Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha. Mol Cell Biol (2002) 4.11
Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J Biol Chem (1995) 4.05
Persistent oxidative stress in cancer. FEBS Lett (1995) 3.85
Dose escalation of a curcuminoid formulation. BMC Complement Altern Med (2006) 3.59
Superoxide dismutase as a target for the selective killing of cancer cells. Nature (2000) 3.44
MAPK pathways in radiation responses. Oncogene (2003) 3.12
Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid Redox Signal (2006) 2.78
Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res (2001) 2.69
Requirement for ERK activation in cisplatin-induced apoptosis. J Biol Chem (2000) 2.66
Radiation-induced cell signaling: inside-out and outside-in. Mol Cancer Ther (2007) 2.56
Chemopreventive and therapeutic effects of curcumin. Cancer Lett (2004) 2.40
Inhibition of mitochondrial respiration: a novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism. J Biol Chem (2003) 2.19
Apoptosis induction in human melanoma cells by inhibition of MEK is caspase-independent and mediated by the Bcl-2 family members PUMA, Bim, and Mcl-1. Clin Cancer Res (2007) 2.15
The concurrent chemoradiation paradigm--general principles. Nat Clin Pract Oncol (2007) 1.98
Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene (1997) 1.98
Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol (2005) 1.94
Inhibition of NF-kappaB, clonogenicity, and radiosensitivity of human cancer cells. J Natl Cancer Inst (1999) 1.69
Cisplatin-induced apoptosis in human malignant testicular germ cell lines depends on MEK/ERK activation. Br J Cancer (2004) 1.68
Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. Mol Cancer Ther (2004) 1.62
Prooxidant activity and cellular effects of the phenoxyl radicals of dietary flavonoids and other polyphenolics. Toxicology (2002) 1.54
Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated I kappa B-alpha. Science (1995) 1.50
A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother Oncol (2003) 1.44
Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene (2004) 1.42
Reactive oxygen species as double-edged swords in cellular processes: low-dose cell signaling versus high-dose toxicity. Hum Exp Toxicol (2002) 1.37
Role of ERK activation in cisplatin-induced apoptosis in OK renal epithelial cells. J Appl Toxicol (2005) 1.36
Putative mechanism for anticancer and apoptosis-inducing properties of plant-derived polyphenolic compounds. IUBMB Life (2000) 1.31
Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers. Mol Pharmacol (2002) 1.31
Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells. Biochem Biophys Res Commun (2005) 1.29
Increased expression of pAKT is associated with radiation resistance in cervical cancer. Br J Cancer (2006) 1.28
Curcumin down regulates smokeless tobacco-induced NF-kappaB activation and COX-2 expression in human oral premalignant and cancer cells. Toxicology (2006) 1.18
Predicting the physiological relevance of in vitro cancer preventive activities of phytochemicals. Acta Pharmacol Sin (2007) 1.15
Curcumin mediated apoptosis in AK-5 tumor cells involves the production of reactive oxygen intermediates. FEBS Lett (1999) 1.15
Phosphatidylinositide 3-kinase/AKT in radiation responses. Histol Histopathol (2004) 1.14
Curcumin induces c-jun N-terminal kinase-dependent apoptosis in HCT116 human colon cancer cells. Carcinogenesis (2004) 1.12
Radiosensitizing and anti-proliferative effects of resveratrol in two human cervical tumor cell lines. Cancer Lett (2002) 1.10
Curcumin protects against radiation-induced acute and chronic cutaneous toxicity in mice and decreases mRNA expression of inflammatory and fibrogenic cytokines. Int J Radiat Oncol Biol Phys (2006) 1.10
Radiosensitizers in cervical cancer. Cisplatin and beyond. Radiat Oncol (2006) 1.07
SYNTHESIS OF DIACETYLDICHLOROFLUORESCIN: A STABLE REAGENT FOR FLUOROMETRIC ANALYSIS. Anal Biochem (1965) 1.07
Induction of senescence in diterpene ester-treated melanoma cells via protein kinase C-dependent hyperactivation of the mitogen-activated protein kinase pathway. Cancer Res (2006) 1.03
Cancer chemoprevention by dietary constituents: a tale of failure and promise. Lancet Oncol (2001) 1.02
Curcumin inhibits UV irradiation-induced oxidative stress and apoptotic biochemical changes in human epidermoid carcinoma A431 cells. J Cell Biochem (2003) 1.02
Mitogen-activated protein kinases and their role in regulation of cellular processes. Gen Physiol Biophys (2002) 0.95
Mitogen-activated protein kinases contribute to reactive oxygen species-induced cell death in renal proximal tubule epithelial cells. Chem Res Toxicol (2002) 0.95
Curcumin: a new radio-sensitizer of squamous cell carcinoma cells. Otolaryngol Head Neck Surg (2005) 0.94
Epidermal growth factor family receptors and inhibitors: radiation response modulators. Semin Radiat Oncol (2003) 0.91
Lack of involvement of ataxia telangiectasia mutated (ATM) in regulation of nuclear factor-kappaB (NF-kappaB) in human diploid fibroblasts. Cancer Res (1999) 0.90
Radiation-induced PARP activation is enhanced through EGFR-ERK signaling. J Cell Biochem (2007) 0.81
ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. EMBO J (2005) 3.79
The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation. EMBO J (2010) 3.76
Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control. EMBO J (2006) 2.41
The PERK/eIF2alpha/ATF4 module of the UPR in hypoxia resistance and tumor growth. Cancer Biol Ther (2006) 1.94
ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth. J Clin Invest (2012) 1.85
Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma. J Clin Invest (2014) 1.81
Control of the hypoxic response through regulation of mRNA translation. Semin Cell Dev Biol (2005) 1.81
19-nor-1 alpha,25-dihydroxyvitamin D2 (paricalcitol) inhibits the proliferation of human pancreatic cancer cells in vitro and in vivo. Cancer Biol Ther (2007) 1.73
Inhibition of fatty acid synthase induces endoplasmic reticulum stress in tumor cells. Cancer Res (2007) 1.64
Pancreatic cancer cells express 25-hydroxyvitamin D-1 alpha-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxyvitamin D3. Carcinogenesis (2004) 1.37
Preferential cytotoxicity of bortezomib toward hypoxic tumor cells via overactivation of endoplasmic reticulum stress pathways. Cancer Res (2008) 1.34
miR-211 is a prosurvival microRNA that regulates chop expression in a PERK-dependent manner. Mol Cell (2012) 1.27
Functional interaction between responses to lactic acidosis and hypoxia regulates genomic transcriptional outputs. Cancer Res (2011) 1.26
Identification and biological evaluation of a novel and potent small molecule radiation sensitizer via an unbiased screen of a chemical library. Cancer Res (2007) 1.23
Dietary curcumin increases antioxidant defenses in lung, ameliorates radiation-induced pulmonary fibrosis, and improves survival in mice. Radiat Res (2010) 1.22
ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis. J Clin Invest (2015) 1.17
ATF4, an ER stress and hypoxia-inducible transcription factor and its potential role in hypoxia tolerance and tumorigenesis. Curr Mol Med (2009) 1.14
HIF-1alpha and p53: the ODD couple? Trends Biochem Sci (2005) 1.12
Inducible priming phosphorylation promotes ligand-independent degradation of the IFNAR1 chain of type I interferon receptor. J Biol Chem (2009) 1.09
Tachpyridine, a metal chelator, induces G2 cell-cycle arrest, activates checkpoint kinases, and sensitizes cells to ionizing radiation. Blood (2005) 1.08
Human colon cancer stem cells are enriched by insulin-like growth factor-1 and are sensitive to figitumumab. Cell Cycle (2011) 1.07
Inhibition of autophagy as a strategy to augment radiosensitization by the dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235. Mol Pharmacol (2012) 1.04
Arachidonic acid-induced gene expression in colon cancer cells. Carcinogenesis (2006) 1.03
Effects of radiation quality and oxygen on clustered DNA lesions and cell death. Radiat Res (2011) 1.01
Vitamin D receptor and p21/WAF1 are targets of genistein and 1,25-dihydroxyvitamin D3 in human prostate cancer cells. Cancer Res (2004) 0.99
The adenoviral E4orf6 protein induces atypical apoptosis in response to DNA damage. J Biol Chem (2006) 0.93
In vivo profiling of hypoxic gene expression in gliomas using the hypoxia marker EF5 and laser-capture microdissection. Cancer Res (2011) 0.93
PERK-ing up autophagy during MYC-induced tumorigenesis. Autophagy (2013) 0.92
Radiation response of cells during altered protein thiol redox. Radiat Res (2003) 0.92
The adenovirus E4orf6 protein inhibits DNA double strand break repair and radiosensitizes human tumor cells in an E1B-55K-independent manner. J Biol Chem (2004) 0.90
Role of p38 protein kinase in the ligand-independent ubiquitination and down-regulation of the IFNAR1 chain of type I interferon receptor. J Biol Chem (2011) 0.90
2-Deoxyglucose and radiosensitization: teaching an old DOG new tricks? Cancer Biol Ther (2006) 0.86
Controlled cell killing by a recombinant nonsegmented negative-strand RNA virus. Virology (2002) 0.85
Disruption of crosstalk between the fatty acid synthesis and proteasome pathways enhances unfolded protein response signaling and cell death. Mol Cancer Ther (2008) 0.84
Thioredoxin reductase-1 mediates curcumin-induced radiosensitization of squamous carcinoma cells. Cancer Res (2010) 0.83
Role of vicinal protein thiols in radiation and cytotoxic responses. Radiat Res (2006) 0.83
The heat shock proteins as targets for radiosensitization and chemosensitization in cancer. Cancer Biol Ther (2011) 0.82
HIF and MIF--a nifty way to delay senescence? Genes Dev (2006) 0.82
Inhibitors of arachidonic acid metabolism act synergistically to signal apoptosis in neoplastic cells. Prostaglandins Leukot Essent Fatty Acids (2005) 0.82
Early exposure to methylphenidate increases fear responses in an aversive context in adult rats. Dev Psychobiol (2007) 0.82
p27Kip1 is essential for the antiproliferative action of 1,25-dihydroxyvitamin D3 in primary, but not immortalized, mouse embryonic fibroblasts. J Biol Chem (2002) 0.81
Location, location, location-makes all the difference for hypoxia in lung tumors. Clin Cancer Res (2010) 0.81
Dual PI3K/mTOR inhibitor NVP-BEZ235 suppresses hypoxia-inducible factor (HIF)-1α expression by blocking protein translation and increases cell death under hypoxia. Cancer Biol Ther (2012) 0.81
c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma. J Clin Invest (2016) 0.80
Identification and characterization of a potent activator of p53-independent cellular senescence via a small-molecule screen for modifiers of the integrated stress response. Mol Pharmacol (2012) 0.79
The chemopreventive and clinically used agent curcumin sensitizes HPV (-) but not HPV (+) HNSCC to ionizing radiation, in vitro and in a mouse orthotopic model. Cancer Biol Ther (2012) 0.79
Enhanced neutralization potency of botulinum neurotoxin antibodies using a red blood cell-targeting fusion protein. PLoS One (2011) 0.78
Inhibition of Hsp27 radiosensitizes head-and-neck cancer by modulating deoxyribonucleic acid repair. Int J Radiat Oncol Biol Phys (2013) 0.78
Piling up the JNK: drug synergy through ER stress. Cancer Biol Ther (2009) 0.77
Mechanisms of enhanced neutralization of botulinum neurotoxin by monoclonal antibodies conjugated to antibodies specific for the erythrocyte complement receptor. Mol Immunol (2013) 0.77
Tumor microenvironment and cellular stress: signaling, metabolism, imaging, and therapeutic targets. Preface. Adv Exp Med Biol (2014) 0.76
pO(2)-dependent NO production determines OPPC activity in macrophages. Free Radic Biol Med (2009) 0.76
The role of autophagy as a mechanism of cytotoxicity by the clinically used agent MDA-7/IL-24. Cancer Biol Ther (2010) 0.75